Skip to main content
Premium Trial:

Request an Annual Quote

Benitec, Medistem Publish Data on Preclinical Rheumatoid Arthritis Effort

Premium

Benitec Biopharma this week announced that it has collaborated with stem cell firm Medistem to treat rheumatoid arthritis in preclinical animal models using their respective technologies.

According to the companies, Benitec's expressed RNAi technology was used to generate dendritic cells that acted as a “tolerogenic vaccine,” blocking the pathological immune response that characterizes arthritis but not affecting normal immune responses.

The findings were reported in the Journal of Translational Medicine.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.